Sunshine Biopharma Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Sunshine Biopharma Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2014 to Q3 2024.
  • Sunshine Biopharma Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending September 30, 2024 was $3.22M.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.22M* +$3.22M Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $3.97M* +$3.97M Jun 30, 2024 10-Q/A 2024-08-20
Q1 2024 $2.83M* +$2.83M Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $2.55M* +$2.55M Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $2.03K +$2.01K +9146% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $2.01K +$1.99K +8280% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.79K +$1.77K +7360% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $1.91K -$5.89K -75.5% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $22.00 -$1.11K -98.1% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $24.00 +$24.00 Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $24.00 +$24.00 Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $7.8K +$5.88K +307% Dec 31, 2021 10-K 2023-04-04
Q3 2021 $1.13K +$1.13K Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $0 $0 Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $0 $0 Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $1.92K +$1.49K +346% Dec 31, 2020 10-K 2022-03-21
Q3 2020 $0 Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $0 -$1.02K -100% Jun 30, 2020 10-Q/A 2020-08-31
Q1 2020 $0 -$119K -100% Mar 31, 2020 10-Q 2020-05-18
Q4 2019 $430 +$430 Dec 31, 2019 10-K 2021-03-30
Q2 2019 $1.02K -$107K -99.1% Jun 30, 2019 10-Q 2019-08-15
Q1 2019 $119K +$26.8K +29% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 $0 $0 Dec 31, 2018 10-K 2020-05-01
Q3 2018 $103K Sep 30, 2018 10-Q 2018-11-16
Q2 2018 $108K Jun 30, 2018 10-Q 2018-08-17
Q1 2018 $92.4K Mar 31, 2018 10-Q 2018-05-22
Q4 2017 $0 Dec 31, 2017 10-K 2019-04-12
Q3 2016 $1.01K Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $77K +$75.1K +3883% Jun 30, 2016 10-Q 2016-08-16
Q1 2016 $103K Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $3.11K +$3.11K Dec 31, 2015 10-Q 2016-11-14
Q2 2015 $1.93K Jun 30, 2015 10-Q 2015-08-06
Q4 2014 $0 Dec 31, 2014 10-Q 2015-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.